| 1 |
Mapoly0009s0167
| [PF12483] E3 Ubiquitin ligase; [KOG1571] Predicted E3 ubiquitin ligase; [GO:0004842] ubiquitin-protein ligase activity; [GO:0007005] mitochondrion organization; [PF13920] Zinc finger, C3HC4 type (RING finger); [PTHR12183] UNCHARACTERIZED RING ZINC FINGER-CONTAINING PROTEIN | 2.83 | 0.7875 |
| 2 |
Mapoly0022s0094
| - | 2.83 | 0.7726 |
| 3 |
Mapoly0023s0095
| - | 3.00 | 0.7787 |
| 4 |
Mapoly0037s0060
| [PF00097] Zinc finger, C3HC4 type (RING finger); [PF04366] Family of unknown function (DUF500); [KOG1843] Uncharacterized conserved protein; [GO:0046872] metal ion binding; [PF01363] FYVE zinc finger; [PTHR15629] SH3YL1 PROTEIN | 3.46 | 0.7136 |
| 5 |
Mapoly0034s0036
| [PTHR22766] RING FINGER PROTEIN 24-RELATED; [GO:0005515] protein binding; [PF13639] Ring finger domain; [GO:0008270] zinc ion binding; [PTHR22766:SF29] SUBFAMILY NOT NAMED | 3.61 | 0.7954 |
| 6 |
Mapoly0152s0028
| [KOG2819] Uncharacterized conserved protein; [PF03676] Uncharacterised protein family (UPF0183); [PTHR13465] UPF0183 PROTEIN | 3.74 | 0.7020 |
| 7 |
Mapoly0105s0029
| [PTHR22903] PLEKHH PROTEIN; [PF00169] PH domain | 6.32 | 0.7006 |
| 8 |
Mapoly0023s0108
| [K01637] isocitrate lyase [EC:4.1.3.1]; [PF00463] Isocitrate lyase family; [GO:0004451] isocitrate lyase activity; [PTHR21631:SF3] ISOCITRATE LYASE; [PTHR21631] ISOCITRATE LYASE/MALATE SYNTHASE; [KOG1260] Isocitrate lyase; [4.1.3.1] Isocitrate lyase.; [GO:0019752] carboxylic acid metabolic process | 6.63 | 0.6466 |
| 9 |
Mapoly0011s0084
| [PTHR13292] UNCHARACTERIZED; [KOG4493] Uncharacterized conserved protein; [PF07855] Protein of unknown function (DUF1649); [PTHR13292:SF0] SUBFAMILY NOT NAMED | 6.71 | 0.7187 |
| 10 |
Mapoly0069s0065
| [PF03023] MviN-like protein; [PTHR11206] MULTIDRUG RESISTANCE PROTEIN | 9.00 | 0.6415 |
| 11 |
Mapoly0154s0035
| [GO:0006097] glyoxylate cycle; [2.3.3.9] Malate synthase.; [K01638] malate synthase [EC:2.3.3.9]; [PTHR21631] ISOCITRATE LYASE/MALATE SYNTHASE; [GO:0004474] malate synthase activity; [KOG1261] Malate synthase; [PF01274] Malate synthase | 10.95 | 0.6495 |
| 12 |
Mapoly0035s0104
| [PF01713] Smr domain; [PF01535] PPR repeat; [PTHR24015] FAMILY NOT NAMED | 15.49 | 0.5699 |
| 13 |
Mapoly0098s0044
| [PF00249] Myb-like DNA-binding domain; [PTHR31499] FAMILY NOT NAMED; [GO:0003682] chromatin binding; [PF14379] MYB-CC type transfactor, LHEQLE motif | 15.59 | 0.6955 |
| 14 |
Mapoly0032s0095
| [PF13855] Leucine rich repeat; [PF13516] Leucine Rich repeat; [GO:0005515] protein binding; [PTHR23125] F-BOX/LEUCINE RICH REPEAT PROTEIN | 16.73 | 0.6870 |
| 15 |
Mapoly0013s0164
| [PF01490] Transmembrane amino acid transporter protein; [PTHR22950] AMINO ACID TRANSPORTER; [KOG1304] Amino acid transporters | 17.97 | 0.6510 |
| 16 |
Mapoly0014s0050
| [PTHR15160] VON HIPPEL-LINDAU PROTEIN; [GO:0004518] nuclease activity; [PF02577] Bifunctional nuclease; [PTHR15160:SF1] VON HIPPEL-LINDAU DISEASE TUMOR SUPPRESSOR | 18.03 | 0.6745 |
| 17 |
Mapoly0053s0103
| - | 18.17 | 0.6861 |
| 18 |
Mapoly0124s0043
| [PF00226] DnaJ domain; [PTHR24077] FAMILY NOT NAMED | 20.20 | 0.6458 |
| 19 |
Mapoly0091s0007
| [GO:0046912] transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer; [K01647] citrate synthase [EC:2.3.3.1]; [PTHR11739] CITRATE SYNTHASE; [PTHR11739:SF1] CITRATE SYNTHASE-RELATED; [GO:0044262] cellular carbohydrate metabolic process; [2.3.3.1] Citrate (Si)-synthase.; [PF00285] Citrate synthase; [KOG2617] Citrate synthase | 20.86 | 0.6665 |
| 20 |
Mapoly0122s0050
| - | 22.25 | 0.6108 |
| 21 |
Mapoly0122s0046
| [PTHR12862] BADF TYPE ATPASE DOMAIN-CONTAINING PROTEIN; [KOG1794] N-Acetylglucosamine kinase; [PF01869] BadF/BadG/BcrA/BcrD ATPase family; [PTHR12862:SF0] SUBFAMILY NOT NAMED | 24.74 | 0.6047 |
| 22 |
Mapoly0053s0036
| [PF00501] AMP-binding enzyme; [KOG1175] Acyl-CoA synthetase; [GO:0008152] metabolic process; [PTHR24095] FAMILY NOT NAMED; [GO:0003824] catalytic activity | 26.93 | 0.6430 |
| 23 |
Mapoly0015s0203
| - | 27.11 | 0.6490 |
| 24 |
Mapoly0061s0004
| [PF14655] Rab3 GTPase-activating protein regulatory subunit N-terminus; [GO:0043087] regulation of GTPase activity; [PTHR12472] RAB3-GAP REGULATORY DOMAIN | 27.13 | 0.6300 |
| 25 |
Mapoly0088s0088
| [PF02672] CP12 domain | 28.98 | 0.6803 |
| 26 |
Mapoly0131s0029
| [PF02450] Lecithin:cholesterol acyltransferase; [KOG2369] Lecithin:cholesterol acyltransferase (LCAT)/Acyl-ceramide synthase; [PTHR11440] LECITHIN-CHOLESTEROL ACYLTRANSFERASE-RELATED; [PTHR11440:SF3] LECITHINE CHOLESTEROL ACYLTRANSFERASE-RELATED; [GO:0006629] lipid metabolic process; [GO:0008374] O-acyltransferase activity | 30.50 | 0.6393 |
| 27 |
Mapoly0016s0076
| [GO:0005615] extracellular space; [PTHR11461] SERINE PROTEASE INHIBITOR, SERPIN; [PTHR11461:SF52] SERINE PROTEASE INHIBITOR, SERPIN; [PF00079] Serpin (serine protease inhibitor); [KOG2392] Serpin | 32.08 | 0.6075 |
| 28 |
Mapoly0004s0292
| [GO:0016020] membrane; [PTHR11654] OLIGOPEPTIDE TRANSPORTER-RELATED; [PF00854] POT family; [KOG1237] H+/oligopeptide symporter; [GO:0006810] transport; [GO:0005215] transporter activity | 32.47 | 0.6293 |
| 29 |
Mapoly0059s0051
| [PTHR15315] RING FINGER PROTEIN 41, 151; [KOG1039] Predicted E3 ubiquitin ligase; [PF13920] Zinc finger, C3HC4 type (RING finger) | 33.23 | 0.6462 |
| 30 |
Mapoly0077s0027
| [K07976] Rab family, other; [GO:0007264] small GTPase mediated signal transduction; [PTHR24073] FAMILY NOT NAMED; [KOG0092] GTPase Rab5/YPT51 and related small G protein superfamily GTPases; [PF00071] Ras family; [GO:0005525] GTP binding | 33.24 | 0.6519 |
| 31 |
Mapoly0020s0054
| [PTHR22766] RING FINGER PROTEIN 24-RELATED; [GO:0005515] protein binding; [PF13639] Ring finger domain; [GO:0008270] zinc ion binding | 33.47 | 0.6565 |
| 32 |
Mapoly0116s0002
| [PTHR21290] SPHINGOMYELIN SYNTHETASE; [PF00536] SAM domain (Sterile alpha motif) | 33.63 | 0.6395 |
| 33 |
Mapoly0003s0260
| [GO:0005737] cytoplasm; [PF04055] Radical SAM superfamily; [PTHR30544] 23S RRNA METHYLTRANSFERASE; [PF13394] 4Fe-4S single cluster domain; [GO:0008173] RNA methyltransferase activity; [GO:0003824] catalytic activity; [GO:0051536] iron-sulfur cluster binding; [GO:0006364] rRNA processing | 35.16 | 0.5529 |
| 34 |
Mapoly0078s0002
| [KOG1417] Homogentisate 1,2-dioxygenase; [GO:0055114] oxidation-reduction process; [PTHR11056:SF0] HOMOGENTISATE 1,2-DIOXYGENASE; [PTHR11056] HOMOGENTISATE 1,2-DIOXYGENASE; [GO:0006559] L-phenylalanine catabolic process; [PF04209] homogentisate 1,2-dioxygenase; [GO:0004411] homogentisate 1,2-dioxygenase activity; [GO:0006570] tyrosine metabolic process | 38.65 | 0.6517 |
| 35 |
Mapoly0036s0071
| - | 39.95 | 0.6218 |
| 36 |
Mapoly0001s0033
| [PTHR11227:SF25] SUBFAMILY NOT NAMED; [PTHR11227] WD-REPEAT PROTEIN INTERACTING WITH PHOSPHOINOSIDES (WIPI)-RELATED; [GO:0005515] protein binding; [PF00400] WD domain, G-beta repeat; [KOG2111] Uncharacterized conserved protein, contains WD40 repeats | 42.36 | 0.6101 |
| 37 |
Mapoly0069s0066
| [PTHR18895] METHYLTRANSFERASE; [KOG3191] Predicted N6-DNA-methyltransferase; [PF13659] Methyltransferase domain | 42.50 | 0.5352 |
| 38 |
Mapoly0067s0002
| [PTHR11019:SF4] THIJ-RELATED; [PF01965] DJ-1/PfpI family; [K03152] 4-methyl-5(b-hydroxyethyl)-thiazole monophosphate biosynthesis; [PTHR11019] THIJ/PFPI; [KOG2764] Putative transcriptional regulator DJ-1 | 47.01 | 0.5874 |
| 39 |
Mapoly0082s0073
| [PTHR15160] VON HIPPEL-LINDAU PROTEIN; [GO:0004518] nuclease activity; [PF02577] Bifunctional nuclease; [PTHR15160:SF1] VON HIPPEL-LINDAU DISEASE TUMOR SUPPRESSOR | 47.62 | 0.6695 |
| 40 |
Mapoly0027s0151
| [KOG4172] Predicted E3 ubiquitin ligase; [PTHR10044] INHIBITOR OF APOPTOSIS; [PF13920] Zinc finger, C3HC4 type (RING finger) | 48.74 | 0.6147 |
| 41 |
Mapoly0054s0047
| - | 49.79 | 0.6254 |
| 42 |
Mapoly0057s0054
| [PF05564] Dormancy/auxin associated protein | 50.55 | 0.6274 |
| 43 |
Mapoly0010s0119
| [3.2.1.51] Alpha-L-fucosidase.; [PTHR10030] ALPHA-L-FUCOSIDASE; [GO:0004560] alpha-L-fucosidase activity; [K01206] alpha-L-fucosidase [EC:3.2.1.51]; [PF01120] Alpha-L-fucosidase; [GO:0005975] carbohydrate metabolic process; [KOG3340] Alpha-L-fucosidase | 52.23 | 0.6385 |
| 44 |
Mapoly0001s0486
| [KOG4172] Predicted E3 ubiquitin ligase; [PTHR10044] INHIBITOR OF APOPTOSIS; [PF10269] Transmembrane Fragile-X-F protein; [PF13920] Zinc finger, C3HC4 type (RING finger) | 52.54 | 0.5421 |
| 45 |
Mapoly0037s0069
| - | 53.72 | 0.6212 |
| 46 |
Mapoly0038s0008
| - | 55.45 | 0.6196 |
| 47 |
Mapoly0024s0085
| [GO:0055114] oxidation-reduction process; [GO:0016491] oxidoreductase activity; [PTHR10696] GAMMA-BUTYROBETAINE HYDROXYLASE-RELATED; [PF02668] Taurine catabolism dioxygenase TauD, TfdA family | 56.28 | 0.6082 |
| 48 |
Mapoly0051s0037
| [PF07714] Protein tyrosine kinase; [KOG0198] MEKK and related serine/threonine protein kinases; [GO:0004672] protein kinase activity; [GO:0006468] protein phosphorylation; [PTHR22967] SERINE/THREONINE PROTEIN KINASE | 58.17 | 0.6266 |
| 49 |
Mapoly0060s0043
| [PTHR12482] UNCHARACTERIZED; [PF05057] Putative serine esterase (DUF676); [KOG4372] Predicted alpha/beta hydrolase | 60.99 | 0.5380 |
| 50 |
Mapoly0019s0144
| [PF02045] CCAAT-binding transcription factor (CBF-B/NF-YA) subunit B; [GO:0006355] regulation of transcription, DNA-dependent; [GO:0003700] sequence-specific DNA binding transcription factor activity; [PTHR12632] TRANSCRIPTION FACTOR NF-Y ALPHA-RELATED | 61.77 | 0.5995 |
